drugset / Trial / NCT03960450
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis
RandomizedSequentialTriple-blindTreatment
Summary
This study was conducted to evaluate the safety and tolerability of BOS-475 following single and repeat topical administration to healthy participants (Part A), and to evaluate the safety and tolerability of 42-day repeat topical administration of BOS-475 to participants with plaque psoriasis (Part B).
Timeline
- Start
- 2019-04-23
- Primary completion
- 2020-01-28
- Completion
- 2020-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BOS-475 | Unknown | 0.5 % | Topical |
| Subject | BOS-475 | Unknown | 1 % | Topical |
| Subject | BOS-475 | Unknown | 2 % | Topical |